Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

J&J to Halt Sales of Four Gynecare Mesh Systems

(Medical-NewsWire.com, June 06, 2012 ) New York, NY – Johnson and Johnson’s Ethicon unit has reportedly planned to stop sales of four of its Gynecare vaginal mesh implants which have been the center of a number of lawsuits alleging that the products caused serious internal injuries. In a letter to U.S. District Judge Joseph R. Goodwin, Johnson and Johnson stated that it asked the FDA for approval to stop “commercializing” the following devices: Gynecare TVT Secur; Gynecare Prosima; Gynecare Prolift; and Gynecare Prolift+M. Ethicon has reportedly asked to continue selling the Gynecare Gynemesh with a label change restricting it usage. For more information on Johnson and Johnson’s decision, please visit http://www.classaction.org/gynecare-vaginal-mesh.html today.

According to reports, Ethicon has asked the FDA to allow it 120 days to end sales of these vaginal mesh systems. The company said that this would provide them the opportunity to notify customers and allow hospitals and surgeons adequate time to choose alternative treatments for their patients. Ethicon “will also discontinue or revise, as appropriate, all marketing materials during this time,” the letter states. In an e-mail, a spokesman for the company said that Ethicon is discontinuing sales of the products worldwide, but is not recalling those already sold or implanted, according to reports.

Amid concerns about vaginal mesh compilations, the FDA in January ordered that Johnson and Johnson and 30 other vaginal mesh manufacturers study organ damage and other side effects linked to the products. Two months later, the FDA announced that Johnson and Johnson had sold its Gynecare Prolift system for three years without the appropriate regulatory clearance. Johnson and Johnson maintained that it could market the Prolift, introduced in March 2005, without approval because it was substantially similar to its Gynemesh, which was already approved. The Prolift mesh was cleared in May 2008.

Hundreds of women have alleged that their vaginal mesh implants have eroded and caused other problems, including severe pain, after the products were inserted transvaginally. Johnson and Johnson and number of other manufacturers are facing lawsuits over these systems, and for patients suffering vaginal mesh complications, it’s not too late to make a claim. If you or a loved one is experiencing problems after vaginal mesh surgery for pelvic organ prolapse or stress urinary incontinence, you may be able to participate in a lawsuit seeking compensation for physical pain, medical expenses and other damages resulting from your complications. To receive a free, no obligation evaluation of your claim, visit ClassAction.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org

Hannah Armstrong

800-449-1970

pressrelease@lawyercentral.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC